Literature DB >> 8739551

Ethological analysis of cholecystokinin (CCKA and CCKB) receptor ligands in the elevated plus-maze test of anxiety in mice.

N J Johnson1, R J Rodgers.   

Abstract

The literature on the effects of CCK receptor manipulations in animal models of anxiety is rife with inconsistency, and the data subject to a variety of methodological and interpretative difficulties. In the present paper, the effects of a range of CCK receptor ligands on anxiety in male mice have been assessed using an ethological version of the elevated plus-maze test. Compounds selected for study were the agonists, CCK-4 and CCK-8s (12.5-100 micrograms/kg), and the antagonists, devazepide, L-365, 260 and PD 135158 (1.0 microgram/kg-1.0 mg/kg). CCK-4 failed to produce any significant behavioural effects over the dose range tested, while treatment with the sulphated octapeptide, CCK-8s, induced signs of behavioural inhibition at 100 microgram/kg without altering anxiety-related indices. Furthermore, in contrast to the clear anxiolytic profile of diazepam (1 mg/kg), and despite the comprehensive behavioural profiles yielded by ethological analysis, all three CCK receptor antagonists studied (devazepide, L-365, 260 and PD 135158) were found to be without significant effect under present test conditions. Together, present findings provide little support for the involvement of CCK receptor mechanisms in anxiety and, in particular, the form of anxiety evoked in mice by exposure to a plus-maze.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8739551     DOI: 10.1007/bf02247441

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  58 in total

1.  Evidence that CCKB receptors mediate the regulation of exploratory behaviour in the rat.

Authors:  J Harro; E Vasar
Journal:  Eur J Pharmacol       Date:  1991-02-14       Impact factor: 4.432

2.  Anxiolytic effects of CCK-B antagonists.

Authors:  B Costall; A M Domeney; J Hughes; M E Kelly; R J Naylor; G N Woodruff
Journal:  Neuropeptides       Date:  1991-07       Impact factor: 3.286

3.  Cholecystokinin and pancreozymin, one single hormone?

Authors:  E Jorpes; V Mutt
Journal:  Acta Physiol Scand       Date:  1966 Jan-Feb

4.  The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder.

Authors:  J Bradwejn; D Koszycki; A Couëtoux du Tertre; H van Megen; J den Boer; H Westenberg
Journal:  Arch Gen Psychiatry       Date:  1994-06

5.  Antianxiety and behavioral suppressant actions of the novel 5-HT1A receptor agonist, flesinoxan.

Authors:  R J Rodgers; J C Cole; A Davies
Journal:  Pharmacol Biochem Behav       Date:  1994-08       Impact factor: 3.533

6.  Evidence for potentiation by CCK antagonists of the effect of cholecystokinin octapeptide in the elevated plus-maze.

Authors:  E Vasar; A Lang; J Harro; M Bourin; J Bradwejn
Journal:  Neuropharmacology       Date:  1994-06       Impact factor: 5.250

7.  Pentagastrin infusions in patients with panic disorder. I. Symptoms and cardiovascular responses.

Authors:  J L Abelson; R M Nesse
Journal:  Biol Psychiatry       Date:  1994-07-15       Impact factor: 13.382

8.  Anxiolytic-like effect of (S)-WAY 100135, a 5-HT1A receptor antagonist, in the murine elevated plus-maze test.

Authors:  R J Rodgers; J C Cole
Journal:  Eur J Pharmacol       Date:  1994-08-22       Impact factor: 4.432

9.  Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol.

Authors:  J C Cole; R J Rodgers
Journal:  Psychopharmacology (Berl)       Date:  1994-03       Impact factor: 4.530

10.  Characterization of receptors for cholecystokinin and related peptides in mouse cerebral cortex.

Authors:  A Saito; I D Goldfine; J A Williams
Journal:  J Neurochem       Date:  1981-08       Impact factor: 5.372

View more
  8 in total

1.  Infralimbic Endothelin1 Is Critical for the Modulation of Anxiety-Like Behaviors.

Authors:  Lin-Lin Bi; Ming Chen; Lei Pei; Shu Shu; Hui-Juan Jin; Hong-Lin Yan; Na Wei; Shan Wang; Xin Yang; Huan-Huan Yan; Meng-Meng Xu; Cheng-Ye Yao; Na Li; Na Tang; Jian-Hua Wu; Hou-Ze Zhu; Hao Li; You Cai; Yu Guo; Yan Shi; Qing Tian; Ling-Qiang Zhu; You-Ming Lu
Journal:  Mol Neurobiol       Date:  2015-04-22       Impact factor: 5.590

2.  Elevated cholecystokininergic tone constitutes an important molecular/neuronal mechanism for the expression of anxiety in the mouse.

Authors:  Qian Chen; Akira Nakajima; Corbin Meacham; Ya-Ping Tang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-28       Impact factor: 11.205

3.  Interaction between the cholecystokinin and endogenous cannabinoid systems in cued fear expression and extinction retention.

Authors:  Mallory E Bowers; Kerry J Ressler
Journal:  Neuropsychopharmacology       Date:  2014-09-01       Impact factor: 7.853

4.  Evaluation of the neuroactive steroid ganaxolone on social and repetitive behaviors in the BTBR mouse model of autism.

Authors:  Tatiana M Kazdoba; Randi J Hagerman; Dorota Zolkowska; Michael A Rogawski; Jacqueline N Crawley
Journal:  Psychopharmacology (Berl)       Date:  2015-11-03       Impact factor: 4.530

5.  Amygdala NRG1-ErbB4 is critical for the modulation of anxiety-like behaviors.

Authors:  Lin-Lin Bi; Xiang-Dong Sun; Jie Zhang; Yi-Sheng Lu; Yi-Hua Chen; Jue Wang; Fei Geng; Fang Liu; Meng Zhang; Ji-Hong Liu; Xiao-Wen Li; Lin Mei; Tian-Ming Gao
Journal:  Neuropsychopharmacology       Date:  2014-10-13       Impact factor: 7.853

Review 6.  Cholecystokinin receptor subtypes: role in the modulation of anxiety-related and reward-related behaviours in animal models.

Authors:  Susan Rotzinger; Franco J Vaccarino
Journal:  J Psychiatry Neurosci       Date:  2003-05       Impact factor: 6.186

7.  Low dose nicotine and antagonism of β2 subunit containing nicotinic acetylcholine receptors have similar effects on affective behavior in mice.

Authors:  Shawn M Anderson; Darlene H Brunzell
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

8.  Enhanced activity of pyramidal neurons in the infralimbic cortex drives anxiety behavior.

Authors:  Laura Berg; Josephine Eckardt; Olivia Andrea Masseck
Journal:  PLoS One       Date:  2019-01-24       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.